AK Medical Holdings Limited reported that no change occurred in its issued share capital on 8 June 2026, which remains at 1.12 billion ordinary shares.

On the same date, the company repurchased 1.10 million shares on the Hong Kong Stock Exchange at prices ranging from HK$5.64 to HK$5.71 per share, spending HK$6.24 million in aggregate. The volume-weighted average cost for this batch was HK$5.67 per share. All of the repurchased shares are designated for cancellation and none will be held as treasury stock.

Including the latest transaction, AK Medical has bought back 15.56 million shares between 6 February and 8 June 2026 under the current mandate approved on 18 June 2025. This represents: • 13.86 % of the 112.27 million shares authorised for repurchase; and • approximately 1.38 % of the company’s present issued share base.

All 15.56 million shares remain outstanding for cancellation; once extinguished, the total share count will fall accordingly.

Under Hong Kong listing rules, AK Medical is subject to a moratorium on new share issues until 8 July 2026 following the latest buyback. No treasury shares were held or sold during the period, and the company confirms full compliance with all applicable regulatory requirements.